Pro-gastrin-releasing peptide (proGRP) in patients with benign and malignant diseases: comparison with CEA, SCC, CYFRA 21-1 and NSE in patients with lung cancer.
暂无分享,去创建一个
N. Viñolas | R. Molina | X. Filella | J. Augé | J. Alicarte | A. Ballesta | J. M. Domingo